The angiotensin II (A II) type 1 receptor (AT1) antagonists represent a new pharmacologic class of drugs. These drugs antagonize A II induced biologic actions. Initial clinical trials suggest that these drugs are effective in the treatment of essential hypertension and hypertensive patients with renal disease.
View Article and Find Full Text PDFChir Narzadow Ruchu Ortop Pol
November 1998